David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 600,000 shares at $1.75 ($1.1M) on 2022-08-09, disclosed to the SEC on 2022-08-11.
Open-market sale of $1.1M VRNA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |